NeuroThera Labs Inc.
Research NeuroThera Labs Inc. (NTLX) on Bullrun: market cap CAD 13.58M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNTLX
- ExchangeV
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyCAD
- Market capCAD 13.58M
- Financial periodQ2 2025
- Net income-CAD 15.61K
- Free cash flow-CAD 6.16K
Valuation Snapshot
latest market cap is CAD 13.58M.
About NeuroThera Labs Inc.
Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules. The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer's disease and agitation, autism spectrum disorder, and status epilepticus. It also focuses on e-commerce operations, which sells hemp-based products. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Newark, Delaware.
Frequently asked questions
What is NeuroThera Labs Inc.'s market cap?
NeuroThera Labs Inc.'s market capitalization is CAD 13.58M.
What does NeuroThera Labs Inc. do?
Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules. The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer's disease and agitation, autism spectrum...